Impact investor

Novartis Venture Fund

Investor type

CVC

Last fund created

1996

AUM

$750 M

Location

Switzerland

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Profile

Investment Focus: Our primary focus is on the development of novel therapeutics and platforms. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program. Invest Globally: We invest in North America, Europe and Israel with approximately USD 750 million under management in committed capital and more than 24 portfolio companies. We continue our strategy of making larger focused investments and anticipate total investments up to USD 30 million per company over its life. Invest Across Healthcare Sector: We make equity investments in Biotechnology/Biopharma life sciences companies. NVF is stage agnostic and engages in seed investments as well as later-stage investments. We typically lead or co-lead an investment and play an active role on company boards.

Industry

Healthcare Services Biotechnology Software Life Sciences HealthTech Digital Pharmaceuticals MedTech Technology

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
3xXcOzq2KfbTnRYl Scientist, general manager, biotech executive and serial entrepreneur
Scientist, general manager, biotech executive and serial entrepreneur
avatar
3xXcOzq2KfbTnRYl Associate
Associate
avatar
3xXcOzq2KfbTnRYl Managing Director
Managing Director
avatar
3xXcOzq2KfbTnRYl Managing Director
Managing Director
avatar
3xXcOzq2KfbTnRYl Principal
Principal
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!